TIS Inc.
3626.TMEDIUMScore: 48.3Core · Weight: 7%· Data as of 2026-04-14
Investment Thesis
Governance reform compounder with exceptional capital return: ¥50B buyback (8.8% of float, 70% executed) + 2.3% dividend = ~11% total shareholder return. ROE 14.9% exceeds TSE 8% target. PE 15.1x is reasonable for this quality. Group Vision 2032 provides long-term roadmap. Reclassify from Healthcare to Governance Reform theme.
Risk
1) Revenue growth essentially zero (+0.4%) — no organic growth driver. 2) Healthcare IT exposure is much smaller than initially assumed — diversified IT services firm. 3) After buyback completes (Sep 2026), no clear next catalyst for re-rating.
Monitoring Trigger
If buyback completes and new program announced, maintain 7%. If no new buyback announced post-Sep 2026, TRIM to 5%. If healthcare IT segment shows >15% growth at earnings, ADD to 9%.
Key Metrics
Supply Chain Evidence
| Evidence | Customer | Product | Detail |
|---|---|---|---|
| confirmed | Japanese financial institutions (banks, insurance, securities, credit card companies) | Core banking, insurance, securities, and payment IT systems | TIS has 50+ years providing banking/insurance/securities systems; leading system integrator in domestic payment services (TIS corporate profile, Annual Report 2025) |
| confirmed | NTQ Solution (Vietnam, capital & business alliance) | Offshore IT services and DX development partnership | TIS entered capital & business alliance with NTQ, a leading Vietnamese IT services provider, in Jan 2025 (Crunchbase, TIS corporate announcements) |
| confirmed | Healthcare providers and public sector clients | Health information-sharing systems and DX solutions for government/healthcare | TIS provides health checkup result sharing systems and digital transformation support for ~15,000 client companies across Japan (TIS corporate profile, Yahoo Finance) |